BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 26446358)

  • 1. Adherence of self-administered subcutaneous methotrexate in patients with chronic plaque-type psoriasis.
    Vidal D; Salleras M; Romaní J; Ribera M; Gallardo F; Viñas M; Xifra A; García-Navarro X; Bordas X; Ferran M; Carrascosa JM
    J Eur Acad Dermatol Venereol; 2016 Nov; 30(11):e131-e132. PubMed ID: 26446358
    [No Abstract]   [Full Text] [Related]  

  • 2. The use of self-administered subcutaneous methotrexate for the treatment of psoriasis.
    Chiaravalloti AJ; Strober BE
    J Drugs Dermatol; 2014 Aug; 13(8):929-31. PubMed ID: 25116970
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effectiveness of Subcutaneous Methotrexate in Chronic Plaque Psoriasis.
    Yesudian PD; Leman J; Balasubramaniam P; Macfarlane AW; Al-Niaimi F; Griffiths CE; Burden AD; Warren RB
    J Drugs Dermatol; 2016 Mar; 15(3):345-9. PubMed ID: 26954320
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The METOP Study: Further Evidence for the Use of Subcutaneous Methotrexate in Psoriasis.
    Morgado-Carrasco D; Fustà-Novell X; Riera Monroig J; Mascaró Galy JM
    Actas Dermosifiliogr; 2017 Nov; 108(9):865-866. PubMed ID: 28583269
    [No Abstract]   [Full Text] [Related]  

  • 5. Methotrexate polyglutamates as a marker of patient compliance and clinical response in psoriasis: a single-centre prospective study.
    Woolf RT; West SL; Arenas-Hernandez M; Hare N; Peters van Ton AM; Lewis CM; Marinaki AM; Barker JN; Smith CH
    Br J Dermatol; 2012 Jul; 167(1):165-73. PubMed ID: 22309614
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Successful treatment of plaque psoriasis with self-administered subcutaneous alefacept.
    Strober BE
    Arch Dermatol; 2005 Dec; 141(12):1602. PubMed ID: 16365271
    [No Abstract]   [Full Text] [Related]  

  • 7. Topical psoriasis therapies and unmet patient needs: the importance of optimizing methotrexate.
    Greenberg R
    Cutis; 2016 Jan; 97(1):55-6. PubMed ID: 26919356
    [No Abstract]   [Full Text] [Related]  

  • 8. Psoriasis: the new and the old.
    Feldman SR
    J Drugs Dermatol; 2014 Aug; 13(8):894. PubMed ID: 25116962
    [No Abstract]   [Full Text] [Related]  

  • 9. Methotrexate for generalized pustular psoriasis in a 2-year-old child.
    Dogra S; Kumaran MS; Handa S; Kanwar AJ
    Pediatr Dermatol; 2005; 22(1):85-6. PubMed ID: 15660909
    [No Abstract]   [Full Text] [Related]  

  • 10. [Methotrexate in psoriasis: do we need to give a test dose?].
    Carretero-Hernández G
    Actas Dermosifiliogr; 2012; 103(1):1-4. PubMed ID: 22093543
    [No Abstract]   [Full Text] [Related]  

  • 11. Effective management of psoriasis symptom worsening during efalizumab therapy without discontinuing treatment: a case study.
    Gisondi P; Giglio MD; Girolomoni G
    J Dermatolog Treat; 2006; 17(3):172-5. PubMed ID: 16854760
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methotrexate versus hydroxycarbamide (hydroxyurea) as a weekly dose to treat moderate-to-severe chronic plaque psoriasis: a comparative study.
    Ranjan N; Sharma NL; Shanker V; Mahajan VK; Tegta GR
    J Dermatolog Treat; 2007; 18(5):295-300. PubMed ID: 17852635
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Infliximab-induced remission of extensive plaque psoriasis.
    Amital H; Ingber A; Rubinow A
    Isr Med Assoc J; 2003 Nov; 5(11):827-8. PubMed ID: 14650114
    [No Abstract]   [Full Text] [Related]  

  • 14. The treatment of psoriasis vulgaris: 1% topical methotrexate gel.
    Eskicirak B; Zemheri E; Cerkezoglu A
    Int J Dermatol; 2006 Aug; 45(8):965-9. PubMed ID: 16911386
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Split doses of Methotrexate in patients with moderate to severe Psoriasis.
    Rodríguez-Zúñiga MJM; Cortez-Franco F; Qujiano-Gomero E
    Actas Dermosifiliogr; 2017; 108(6):603-604. PubMed ID: 28173920
    [No Abstract]   [Full Text] [Related]  

  • 16. Addition of low-dose methotrexate to infliximab in the treatment of a patient with severe, recalcitrant pustular psoriasis.
    Barland C; Kerdel FA
    Arch Dermatol; 2003 Jul; 139(7):949-50. PubMed ID: 12873907
    [No Abstract]   [Full Text] [Related]  

  • 17. Methotrexate-betamethasone weekly oral pulse in psoriasis.
    Gupta R; Gupta S
    J Dermatolog Treat; 2007; 18(5):291-4. PubMed ID: 17852636
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetic profile of methotrexate in psoriatic skin via the oral or subcutaneous route using dermal microdialysis showing higher methotrexate bioavailability in psoriasis plaques than in non-lesional skin.
    Quist SR; Quist J; Birkenmaier J; Stauch T; Gollnick HP
    J Eur Acad Dermatol Venereol; 2016 Sep; 30(9):1537-43. PubMed ID: 27005005
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of systemic methotrexate in two fixed doses of 10 mg or 25 mg orally once weekly in adult patients with severe plaque-type psoriasis: a prospective, randomized, double-blind, dose-ranging study.
    Dogra S; Krishna V; Kanwar AJ
    Clin Exp Dermatol; 2012 Oct; 37(7):729-34. PubMed ID: 22830389
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methotrexate, a drug for the years to come.
    Naldi L; Saunes M
    Br J Dermatol; 2011 Aug; 165(2):230-1. PubMed ID: 21777212
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.